Cited 0 times in
Development of a DAS28-based pharmacodynamic endpoint to efficiently evaluate the dose-response relation of antirheumatic effect of JAK3 inhibitors
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.